The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis

被引:102
作者
Li, Hailong [1 ,2 ]
Xie, Shoupin [3 ]
Liu, Min [1 ]
Chen, Zhaofeng [1 ,2 ]
Liu, Xiaojun [1 ]
Wang, Li [1 ]
Li, Dayan [1 ]
Zhou, Yongning [1 ,2 ]
机构
[1] Lanzhou Univ, Div Gastroenterol & Hepatol, Hosp 1, Lanzhou 730000, Gansu, Peoples R China
[2] Key Lab Gastrointestinal Dis Gansu, Lanzhou 730000, Gansu, Peoples R China
[3] First Peoples Hosp Lanzhou, Lanzhou 730050, Gansu, Peoples R China
关键词
miRNA; PCR array; gastric cancer; tumor suppressors; TUMOR-SUPPRESSOR; METASTASIS SUPPRESSOR; CELL-PROLIFERATION; MICRORNA; EXPRESSION; ACTS; IDENTIFICATION; BIOMARKERS; CARCINOMA; MIR-133B;
D O I
10.3892/ijo.2014.2415
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dysregulated miRNAs in gastric cancer are usually screened by miRNA microarray from clinical samples, however, reports have indicated that results of each miRNA microarray screening are considerably different, and dysregulated miRNAs, especially downregulated miRNAs were contradictory. In view of this, the Human Cancer Pathway Finder miRNA PCR array was applied to compare 7 gastric cancer cell lines AGS, SGC-7901, MKN-45, MKN-28, MGC-803, BCG-823, and HGC-27 with an immortalized normal gastric cell line, GES-1 in cancer pathway-related miRNA expression profile, followed by qPCR verification, the clinical significance of downregulated miRNAs and the Enriched KEGG pathways and GO terms of their target genes were analyzed. Thirty-eight miRNAs were upregulated, and four miRNAs were downregulated in gastric cancer cell lines. Clinical significance of 4 miRNAs including mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tissue compared with adjacent non-tumor tissues of 58 patients indicated that the low-expression group of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p showed more extensive lymph node metastasis, lymphatic invasion, venous invasion, high-stage Borrmann type, lymphatic invasion and poor differentiation than that of the high-expression groups, respectively (P<0.05; chi(2) test). Enriched KEGG pathway analyses showed that most of the targeted genes of the 4 miRNAs concentrated on 37 signaling pathways, and were involved in the same pathways related to cancer. Enriched GO terms showed that targeted genes of the 4 miRNAs concentrated on 339 terms, 24 of 339 terms are associated with cancer tumorigenesis. The Human Cancer Pathway Finder miRNA PCR array could be used to screen dysregulated miRNAs effectively, and 4 screened miRNAs, mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p were found to be downregulated in gastric cancer. Clinical significance and bioinformatic analysis on the target genes of these 4 miRNAs indicated that they were deeply involved in tumorigenesis, suggesting roles such as miRNA tumor suppressors in gastric cancer tumorigenesis which could be applied in gastric cancer diagnosis and prognosis.
引用
收藏
页码:197 / 208
页数:12
相关论文
共 38 条
[1]   MicroRNAs: Novel Biomarkers for Human Cancer [J].
Bartels, Claudine L. ;
Tsongalis, Gregory J. .
CLINICAL CHEMISTRY, 2009, 55 (04) :623-631
[2]   Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues [J].
Callari, Maurizio ;
Dugo, Matteo ;
Musella, Valeria ;
Marchesi, Edoardo ;
Chiorino, Giovanna ;
Grand, Maurizia Mello ;
Pierotti, Marco Alessandro ;
Daidone, Maria Grazia ;
Canevari, Silvana ;
De Cecco, Loris .
PLOS ONE, 2012, 7 (09)
[3]   Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer [J].
Carvalho, Joana ;
van Grieken, Nicole C. ;
Pereira, Patricia M. ;
Sousa, Sonia ;
Tijssen, Marianne ;
Buffart, Tineke E. ;
Diosdado, Begona ;
Grabsch, Heike ;
Santos, Manuel A. S. ;
Meijer, Gerrit ;
Seruca, Raquel ;
Carvalho, Beatriz ;
Oliveira, Carla .
JOURNAL OF PATHOLOGY, 2012, 228 (01) :31-44
[4]   microRNAs as novel epigenetic biomarkers for human cancer [J].
Cortes-Sempere, Maria ;
Ibanez de Caceres, Inmaculada .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (06) :357-362
[5]   microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer [J].
Crone, Stephanie Geisler ;
Jacobsen, Anders ;
Federspiel, Birgitte ;
Bardram, Linda ;
Krogh, Anders ;
Lund, Anders H. ;
Friis-Hansen, Lennart .
MOLECULAR CANCER, 2012, 11
[6]  
D'Andrade Petula N, 2012, Methods Mol Biol, V822, P85, DOI 10.1007/978-1-61779-427-8_6
[7]   Clinical application of microRNA in gastric cancer in Eastern Asian area [J].
Gao, Ming ;
Yin, Hao ;
Fei, Zhe-Wei .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (13) :2019-2027
[8]   Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues [J].
Guo, Junming ;
Miao, Ying ;
Xiao, Bingxiu ;
Huan, Rong ;
Jiang, Zhen ;
Meng, Dan ;
Wang, Yanjun .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (04) :652-657
[9]   microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer [J].
Hou, Zhibo ;
Yin, Haitao ;
Chen, Cong ;
Dai, Xinzheng ;
Li, Xiaolin ;
Liu, Baorui ;
Fang, Xuefeng .
MOLECULAR MEDICINE REPORTS, 2012, 6 (03) :501-506
[10]   MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis [J].
Hou, Zhibo ;
Xie, Li ;
Yu, Lixia ;
Qian, Xiaoping ;
Liu, Baorui .
MEDICAL ONCOLOGY, 2012, 29 (02) :886-892